Search

Your search keyword '"Shi, Haoqing"' showing total 23 results
Start Over Author "Shi, Haoqing"
23 results on '"Shi, Haoqing"'

5. Automatic High-Performance Neural Network Construction for Channel Estimation in IRS-Aided Communications

Author

Shi, Haoqing, Huang, Yongming, Jin, Shi, Wang, Zheng, and Yang, Luxi

Abstract

Accurate channel estimation is an essential prerequisite for achieving significant performance gains in intelligent reflecting surface (IRS)-aided communication systems. Recent studies have shown that deep neural network-based channel estimation holds promise as a competitive alternative to conventional methods. However, existing neural network-based approaches typically involve manual design of network architectures through a trial-and-error process, demanding extensive domain knowledge and human resources. In this paper, we propose an automatic approach to construct a high-performance neural network architecture for channel estimation. Our method, called the channel estimation neural network architecture search (CENAS), utilizes a truncated back-propagation optimization search strategy to explore a neural network tailored for channel estimation. By carefully designing a search space tailored to channel estimation tasks, the automatically constructed network surpasses both conventional and deep learning-based channel estimation algorithms. The convergence of our framework’s network construction process is comprehensively analyzed, providing formal evidence of its convergence properties. Additionally, the proposed framework exhibits good generalization and applicability by allowing flexible adjustment of hyperparameters to generate networks with varying scales. Empirical results show the stability and the improved performance of CENAS framework, validating its effectiveness and desirability.

Published
2024
Full Text
View/download PDF

6. Genomic and epigenomic evolution of metastatic prostate cancer: the first warm autopsy in China

Author

Zhang, Wenhui, primary, Wang, Yan, additional, Qu, Min, additional, Shi, Haoqing, additional, Lu, Xin, additional, Yang, Qingsong, additional, Liu, Fang, additional, Wang, Tao, additional, Wang, Ziwei, additional, Lian, Bijun, additional, Chen, Ling, additional, Yin, Xiaoyi, additional, Yu, Yongwei, additional, Li, Jing, additional, Gao, Xu, additional, and Liao, Zhuan, additional

Published
2023
Full Text
View/download PDF

10. Integrative transcriptome and proteome analyses of clear cell renal cell carcinoma develop a prognostic classifier associated with thrombus

Author

Shi, Xiaolei, primary, Pang, Qingyang, additional, Nian, Xinwen, additional, Jiang, Aimin, additional, Shi, Haoqing, additional, Liu, Wenqiang, additional, Gan, Xinxin, additional, Gao, Yisha, additional, Yang, Yiren, additional, Ji, Jin, additional, Tan, Xiaojie, additional, Xiao, Chengwu, additional, and Zhang, Wei, additional

Published
2023
Full Text
View/download PDF

17. Intratumor heterogeneity and clonal evolution revealed in castration-resistant prostate cancer by longitudinal genomic analysis

Author

Zhang, Wenhui, primary, Wang, Tao, additional, Wang, Yan, additional, Zhu, Feng, additional, Shi, Haoqing, additional, Zhang, Jili, additional, Wang, Ziwei, additional, Qu, Min, additional, Zhang, Huaru, additional, Wang, Tianyi, additional, Qian, Yuping, additional, Yang, Jinjian, additional, Gao, Xu, additional, and Li, Jing, additional

Published
2022
Full Text
View/download PDF

18. Integrative Transcriptome and Proteome Analyses of Clear Cell Renal Cell Carcinoma Develop a Prognostic Classifier Associated with Thrombus

Author

Shi, Xiaolei, primary, Pang, Qingyang, additional, Nian, Xinwen, additional, Jiang, Aimin, additional, Shi, Haoqing, additional, Liu, Wenqiang, additional, Gan, Xinxin, additional, Gao, Yisha, additional, Yang, Yiren, additional, Ji, Jin, additional, Tan, Xiaojie, additional, Xiao, Chengwu, additional, and Zhang, Wei, additional

Published
2022
Full Text
View/download PDF

23. The status, limitation and improvement of adoptive cellular immunotherapy in advanced urologic malignancies.

Author

Shi H, Qi X, Ma B, Cao Y, Wang L, Sun L, and Niu H

Abstract

In recent years, immunotherapy has been gradually established as the fourth frequently adopted antitumor therapy, following surgery, chemotherapy and radiotherapy, for advanced urologic malignancies with an improved understanding of theoretical basis, such as molecular biology and immunology. Thereinto, adoptive cellular immunotherapy (ACI) has become one of the hotspots, which comprises a variety of treatment approaches, such as TIL, CIK cell, γδ T cell, CAR-engineered T cell and Allogeneic stem cell transplantation (alloSCT). Although preclinical efficacy has been demonstrated remarkably, clinical trials could not consistently show the benefit due to multi-factors in complex immunosuppressive microenvironment in vivo compared to that of in vitro. Here we review some timely aspects of ACI for advanced urologic malignancies, and describe the current status and limitation of immunotherapy from the cellular level. It's our expectation to provide prompting consideration of novel combinatorial ACI strategies and a resurgence of interest in ACI for advanced urologic malignancies.

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results